Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China · Delayed Price · Currency is CNY 10.14
+0.16 (1.60%)
At close: May 8, 2026
SHE:301301 Market Cap
SHE:301301 has a market cap or net worth of 22.61 billion as of May 8, 2026. Its market cap has decreased by -16.57% in one year.
Market Cap
22.61B
Enterprise Value
23.19B
Revenue
4.41B
Ranking
n/a
PE Ratio
38.76
Stock Price
10.14
Market Cap Chart
Since December 27, 2022, SHE:301301's market cap has increased from 22.34B to 22.61B, an increase of 1.23%. That is a compound annual growth rate of 0.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 22.61B | - |
| Dec 31, 2025 | 22.61B | -14.39% |
| Dec 31, 2024 | 26.41B | 41.47% |
| Dec 29, 2023 | 18.67B | -6.15% |
| Dec 30, 2022 | 19.89B | -10.95% |
| Dec 27, 2022 | 22.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Tiantan Biological Products | 28.38B |
| BrightGene Bio-Medical Technology | 28.16B |
| Suzhou Zelgen Biopharmaceuticals | 26.85B |
| Hualan Biological Engineering | 26.57B |
| Xiamen Amoytop Biotech | 23.33B |
| Sinocelltech Group | 19.89B |
| Jinyu Bio-technology | 16.49B |
| Mabwell (Shanghai) Bioscience | 15.10B |